Riken Vitamin Co., Ltd. (JP:4526)
:4526
Want to see JP:4526 full AI Analyst Report?
Total Valuation
Riken Vitamin Co., Ltd. has a market cap or net worth of ¥63.51B. The enterprise value is ¥68.56B.
Market Cap¥63.51B
Enterprise Value¥68.56B
Share Statistics
Riken Vitamin Co., Ltd. has 30,705,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,705,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Riken Vitamin Co., Ltd.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.80%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)4.80%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee51.86M
Profits Per Employee3.79M
Employee Count1,857
Asset Turnover0.83
Inventory Turnover3.02
Valuation Ratios
The current PE Ratio of Riken Vitamin Co., Ltd. is 12.1. Riken Vitamin Co., Ltd.’s PEG ratio is -0.52.
PE Ratio12.1
PS Ratio0.88
PB Ratio1.02
Price to Fair Value1.02
Price to FCF91.71
Price to Operating Cash Flow0.00
PEG Ratio-0.52
Income Statement
In the last 12 months, Riken Vitamin Co., Ltd. had revenue of 96.30B and earned 7.04B in profits. Earnings per share was 238.17.
Revenue96.30B
Gross Profit29.77B
Operating Income6.90B
Pretax Income10.24B
Net Income7.04B
EBITDA11.58B
Earnings Per Share (EPS)238.17
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Riken Vitamin Co., Ltd. pays an annual dividend of ¥55, resulting in a dividend yield of 3.63%
Dividend Per Share¥55
Dividend Yield3.63%
Payout Ratio34.35%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change15.65%
50-Day Moving Average2.84K
200-Day Moving Average2.86K
Relative Strength Index (RSI)49.00
Average Volume (3m)91.61K
Important Dates
Riken Vitamin Co., Ltd. upcoming earnings date is Aug 12, 2026, TBA (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date―
Financial Position
Riken Vitamin Co., Ltd. as a current ratio of 3.41, with Debt / Equity ratio of 8.57%
Current Ratio3.41
Quick Ratio2.27
Debt to Market Cap0.08
Net Debt to EBITDA-1.12
Interest Coverage Ratio60.54
Taxes
In the past 12 months, Riken Vitamin Co., Ltd. has paid 3.20B in taxes.
Income Tax3.20B
Effective Tax Rate0.31
Enterprise Valuation
Riken Vitamin Co., Ltd. EV to EBITDA ratio is 6.21, with an EV/FCF ratio of 77.73.
EV to Sales0.75
EV to EBITDA6.21
EV to Free Cash Flow77.73
EV to Operating Cash Flow12.06
Balance Sheet
Riken Vitamin Co., Ltd. has ¥20.05B in cash and marketable securities with ¥10.13B in debt, giving a net cash position of ¥9.91B billion.
Cash & Marketable Securities¥20.05B
Total Debt¥10.13B
Net Cash¥9.91B
Net Cash Per Share¥322.85
Tangible Book Value Per Share¥2.82K
Margins
Gross margin is 30.91%, with operating margin of 7.17%, and net profit margin of 7.31%.
Gross Margin30.91%
Operating Margin7.17%
Pretax Margin10.64%
Net Profit Margin7.31%
EBITDA Margin12.02%
EBIT Margin7.17%
Analyst Forecast
The average price target for Riken Vitamin Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast0.75%
EPS Growth Forecast-23.19%